Johnson & Johnson Ranks 72nd in Trading Volume with $944 Million as Stock Price Rises for Third Day

On March 28, 2025, Johnson & Johnson (JNJ) saw a trading volume of $944 million, ranking 72nd in the day's stock market activity. The company's stock price increased by 0.36%, marking the third consecutive day of gains, with a total increase of 1.67% over the past three days.

Johnson & Johnson has announced a significant investment of $55 billion over the next four years to enhance its manufacturing capabilities in the United States. This move is part of a broader trend among major pharmaceutical companies to reshoring their operations, following similar announcements from Lilly and Merck.

In a separate development, Johnson & Johnson and its consumer health products subsidiary, Kenvue Inc., are facing a lawsuit from investors. The lawsuit alleges that the companies did not adequately address concerns raised by the U.S. Food and Drug Administration (FDA) regarding certain products. This legal challenge could have implications for the company's reputation and financial performance.